A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma
Clinical trial NCT02718833 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02718833
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-21
- Primary completion
- 2026-12-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.